625 followers
[hal-02510696] Cost-Effectiveness of Three Alternative Boosted Protease Inhibitor-Based Second-Line Regimens in HIV-Infected Patients in West and Central Africa. by S. Boyer et al. https://t.co/xIXIE1Ixb1
[hal-02510696] Cost-Effectiveness of Three Alternative Boosted Protease Inhibitor-Based Second-Line Regimens in HIV-Infected Patients in West and Central Africa. by S. Boyer et al. https://t.co/xIXIE1Ixb1
#HealthEconJA Cost-Effectiveness of Three Alternative Boosted Protease Inhibitor-Based Second-Line Regimens in HIV-Infected Patients in West and Central Africa https://t.co/10VtZKupNz